Junxia Li
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Genetics 11
- Inflammatory Bowel Disease 6
- Genetic Associations and Epidemiology 2
-
- MicroRNA in disease regulation 5
- Co-authors
- Qingyuan Huang (7 shared papers)Yun Bai (4 shared papers)Ren‐Ping Xiong (3 shared papers)Yujie Shi (4 shared papers)Xueqing Xu (3 shared papers)Gang Xiong (3 shared papers)Guoliang Xia (3 shared papers)Meijia Zhang (3 shared papers)
In The Last Decade
Junxia Li
45 papers receiving 1k citations
Junxia Li's Hit Papers
Peers
Comparison fields: 5 of 86
- Nephrology 131
- Cancer Research 135
- Genetics 131
- Molecular Biology 252
- Hepatology 32
Countries citing papers authored by Junxia Li
This map shows the geographic impact of Junxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxia Li more than expected).
Fields of papers citing papers by Junxia Li
This network shows the impact of papers produced by Junxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxia Li. The network helps show where Junxia Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junxia Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 183 | |
| 2 | Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis Hit paper breakdown → | 2024 | 133 |
| 3 | 2012 | 65 | |
| 4 | 2008 | 61 | |
| 5 | 2014 | 54 | |
| 6 | 2011 | 53 | |
| 7 | 2012 | 53 | |
| 8 | 2020 | 49 | |
| 9 | 2019 | 46 | |
| 10 | 2019 | 36 | |
| 11 | 2011 | 26 | |
| 12 | 2022 | 22 | |
| 13 | 2012 | 21 | |
| 14 | 2014 | 21 | |
| 15 | 2021 | 20 | |
| 16 | 2022 | 20 | |
| 17 | 2022 | 18 | |
| 18 | 2023 | 16 | |
| 19 | 2020 | 15 | |
| 20 | 2023 | 14 |
About Junxia Li
Junxia Li is a scholar working on Genetics, Cancer Research, Molecular Biology, Nephrology and Hematology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), MicroRNA in disease regulation (5 papers), Pulmonary Hypertension Research and Treatments (2 papers), Schizophrenia research and treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Reproductive Biology and Fertility (2 papers), Genetic Associations and Epidemiology (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Nephrology (131 citations), Cancer Research (135 citations), Genetics (131 citations), Molecular Biology (252 citations) and Hepatology (32 citations). Junxia Li has collaborated with scholars based in China and Taiwan. Frequent co-authors include Qingyuan Huang, Yun Bai, Ren‐Ping Xiong, Yujie Shi, Xueqing Xu, Gang Xiong, Guoliang Xia, Meijia Zhang, Jun Yan and Xingying Guan. Their work appears in journals such as Journal of Cellular Physiology, American Journal of Physiology-Cell Physiology, Journal of Translational Medicine, BMC Gastroenterology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.